Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127642461 | 12764246 | 1 | I | 20140409 | 20160920 | 20160920 | EXP | AU-SA-2014SA045514 | AVENTIS | 0.00 | A | F | Y | 0.00000 | 20160920 | CN | AU | AU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127642461 | 12764246 | 1 | PS | FEXOFENADINE | FEXOFENADINEFEXOFENADINE HYDROCHLORIDE | 1 | Oral | UNKNOWN | 20872 | 180 | MG | QOD | |||||||
| 127642461 | 12764246 | 2 | SS | FEXOFENADINE | FEXOFENADINEFEXOFENADINE HYDROCHLORIDE | 1 | Oral | UNKNOWN | 20872 | 180 | MG | QOD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127642461 | 12764246 | 1 | Paraesthesia |
| 127642461 | 12764246 | 2 | Pruritus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127642461 | 12764246 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127642461 | 12764246 | Anxiety | |
| 127642461 | 12764246 | Hyperthyroidism | |
| 127642461 | 12764246 | Therapeutic response unexpected | |
| 127642461 | 12764246 | Thyroiditis subacute |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127642461 | 12764246 | 1 | 20131101 | 0 | ||
| 127642461 | 12764246 | 2 | 20131101 | 0 |